Loading…
Monday September 30, 2024 4:45pm - 5:30pm EDT
  • Explore strategies for enhancing integration and communication between R&D, clinical, and commercial teams.
  • Discuss the importance of aligning these teams early in the development process to ensure successful asset progression.
  • Share case studies demonstrating successful cross-functional collaboration and its impact on project outcomes.
Speakers
avatar for Erica Paine

Erica Paine

Vice President, Value & Market Access, Chiesi
avatar for Sue Nemetz

Sue Nemetz

Founder & CEO, Corval
avatar for John Harlow

John Harlow

Chief Commercial Officer, Melinta Therapeutics
avatar for Cathi Ahearn

Cathi Ahearn

Senior Vice President, Worldwide Commercial Portfolio Strategy, Bristol Myers Squibb
avatar for Josh Meidenbauer

Josh Meidenbauer

Senior Director, New Product Planning, Intellia Therapeutics
Monday September 30, 2024 4:45pm - 5:30pm EDT
  General Session
  • QTAG NPPfeaturedsessionsHP
Log in to leave feedback.

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link